An exciting new use for an old drug is shining a spotlight on the potential for repurposing previously approved drugs to treat malignant mesothelioma faster and more effectively. Malignant mesothelioma is the cancer most closely associated with the mineral asbestos. Although it’s incidence is slowly declining in some parts of the world, mesothelioma continues to rise in many poor countries where asbestos regulation is lax … Continue reading Could Drug “Repurposing” Be the Cure for Mesothelioma?
There is some compelling new evidence on the economic impact of banning the mineral asbestos, the primary cause of the malignant mesothelioma. According to a team of economic experts and researchers at both the World Health Organization and Australia’s Asbestos Diseases Research Institute, asbestos bans don’t have a negative impact on a country’s gross domestic product or employment rates. The news comes as rates of … Continue reading Malignant Mesothelioma Versus Asbestos Use: Which Costs More?
New technology could eventually make it easier, less painful, and less expensive to track the progress of patients undergoing treatment for malignant mesothelioma and other cancers. A research team led by University of Wisconsin-Madison pharmacy professor Seungpyo Hong has developed what they say is a more efficient method for capturing free-floating cancer cells in the blood. The developers say the system is far more effective … Continue reading New Technology Could Change How Mesothelioma Treatment is Monitored
New evidence suggests that a pulmonary rehabilitation program that comes to them might help patients recover after pleural mesothelioma treatment. Experts in pulmonary cancers at several French institutions recently published what they called a “real-life feasibility study” of home-based rehab in patients who had received chemotherapy for either lung cancer or malignant pleural mesothelioma. Previous research has shown that these patients are typically less physically … Continue reading Home-Based Rehab Helps Mesothelioma Patients Bounce Back After Chemotherapy
A new report suggests that too many mesothelioma patients and their families may not be coping as well as they could be with the implications of their diagnosis. Italian researchers in environmental health, occupational disease, and psychology conducted extensive interviews with 10 mesothelioma patients and 9 of their caregivers. In a report in the journal Frontiers in Psychology, the team concluded that families with malignant … Continue reading Measuring the Emotional Toll of Mesothelioma
When it comes to accurately assessing the extent of an individual case of malignant pleural mesothelioma, Positron Emission Tomography (PET) may be more effective than Computed Tomography (CT). A combination of the two is even better. That conclusion comes from researchers at the University of Toronto who analyzed the cases of more than 100 mesothelioma patients being considered for multimodality therapy at Princess Margaret Cancer … Continue reading PET Beats CT in Study of Mesothelioma Staging Tools
A new study is asking the question, is it possible to remove a malignant mesothelioma tumor with pleurectomy-decortication (P/D) without risking the spread of new tumors? P/D, the lung-sparing pleural mesothelioma surgery, has become the preferred approach in many cases where mesothelioma has not spread to the lung tissue. Most studies have found that P/D has a lower complication rate, produces less pain, and allows for faster … Continue reading New Surgical Technique May Improve Mesothelioma Survival
Researchers at one of the nation’s top cancer institutes are betting on a combination of radiation and immunotherapy in the continued pursuit of better treatments for malignant mesothelioma. Memorial Sloan Kettering in New York is now recruiting relapsed mesothelioma patients into a safety and efficacy study of stereotactic body radiation therapy (SBRT) and the immunotherapy drug avelumab. The new trial is based on the idea … Continue reading New Mesothelioma Treatment Combines Immunotherapy and Targeted Radiation
A new Japanese study is calling into question the value of a common prognostic test for people with malignant pleural mesothelioma. The test is called the neutrophil-to-lymphocyte ratio or NLR and it is used in many types of diseases, including mesothelioma, as a marker for inflammation. But in a new report published in the journal In Vivo, researchers with the Hyogo Prefectural Amagasaki General Medical … Continue reading Blood Test May Not Predict Mesothelioma Survival as Well as Hoped
Australia’s legacy of asbestos mining and use continues to haunt it almost fifteen years after the country banned all forms of asbestos almost fifteen years ago. A new report published in the International Journal of Environmental Research and Public Health suggests that, although asbestos consumption peaked in Australia in the 1970s, malignant mesothelioma and other asbestos-related diseases continue to be a significant public health issue. … Continue reading Mesothelioma Persists in Australia Despite Asbestos Ban